Veru, Inc. (VERU)
2.56
-0.07
(-2.66%)
USD |
NASDAQ |
Dec 10, 16:00
2.56
0.00 (0.00%)
After-Hours: 16:06
Veru EPS Diluted (Quarterly): -0.5003 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Onconetix, Inc. | -6.250 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.323M |
| Total Expenses (Quarterly) | 7.323M |
| Enterprise Value | 26.80M |
| Earnings Yield | -36.58% |
| Normalized Earnings Yield | -52.07 |